Approval · Notice of Compliance 32736 · 2024
XOFIGO: Notice of Compliance 32736
Issued February 19, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32736
- Date
- February 19, 2024
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in product release testing procedure
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XOFIGO | Not yet assigned | — |
Medicinal ingredients
- RADIUM RA-223 DICHLORIDE 1,100 KBQ per ML